Agios Pharma (8AP) Q2 2024 Earnings Report
CH:8AP Q2 2024 EPS Results
- Actual EPS
- -CHF 1.39
- Consensus EPS
- -CHF 1.32
- Beat/Miss
- Missed by -CHF 0.07
- One Year Ago EPS
- -CHF 1.25
CH:8AP Q2 2024 Revenue Results
- Actual Revenue
- CHF 7.11M
- Expected Revenue
- CHF 7.71M
- Beat/Miss
- Missed by -CHF 601.28K
- YoY Revenue Growth
- +28.35%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- Before Open
- Conference Call
- Thursday, August 1, 2024
CH:8AP Upcoming Earnings
Agios Pharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:8AP Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:8AP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -1.03- | -1.47 | ― | ― |
| Jul 30, 2026 | 2026 (Q2) | -1.37-1.39 | -1.59 | 12.44% (+0.20) | |
| Apr 29, 2026 | 2026 (Q1) | -1.49-1.39 | -1.28 | -9.03% (-0.12) | |
| Feb 12, 2026 | 2025 (Q4) | -1.61-1.53 | -1.19 | -29.17% (-0.35) | |
| Oct 30, 2025 | 2025 (Q3) | -1.56-1.47 | 13.38 | -110.97% (-14.85) | |
| Jul 31, 2025 | 2025 (Q2) | -1.49-1.59 | -1.39 | -14.20% (-0.20) | |
| May 01, 2025 | 2025 (Q1) | -1.46-1.28 | -1.2 | -6.90% (-0.08) | |
| Feb 13, 2025 | 2024 (Q4) | -1.39-1.19 | -1.41 | 15.79% (+0.22) | |
| Oct 31, 2024 | 2024 (Q3) | 12.5513.38 | -1.35 | 1089.02% (+14.73) | |
| Aug 01, 2024 | 2024 (Q2) | -1.32-1.39 | -1.25 | -11.92% (-0.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
